Literature DB >> 32575136

Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink.

Nuccia Morici1,2, Maurizio Bottiroli3, Roberto Fumagalli3,4, Claudia Marini1, Marco Cattaneo5,6.   

Abstract

Entities:  

Year:  2020        PMID： 32575136     DOI： 10.1055/s-0040-1713400

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  10 in total

Review 1.  Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.

Authors:  Lucas C Godoy; Ewan C Goligher; Patrick R Lawler; Arthur S Slutsky; Ryan Zarychanski
Journal:  CMAJ       Date:  2020-08-16       Impact factor: 8.262

Review 2.  Adamalysins in COVID-19 - Potential mechanisms behind exacerbating the disease.

Authors:  Ivo Ricardo de Seabra Rodrigues Dias; Zhijian Cao; Hang Fai Kwok
Journal:  Biomed Pharmacother       Date:  2022-04-15       Impact factor: 7.419

Review 3.  Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19.

Authors:  Gustavo A Argañaraz; Julys da Fonseca Palmeira; Enrique R Argañaraz
Journal:  Cell Commun Signal       Date:  2020-12-27       Impact factor: 5.712

4.  Association between thrombocytopenia and 180-day prognosis of COVID-19 patients in intensive care units: A two-center observational study.

Authors:  Yuan Zhu; Jing Zhang; Yiming Li; Fang Liu; Qing Zhou; Zhiyong Peng
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

Review 5.  High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis.

Authors:  Mehrdad Rostami; Hassan Mansouritorghabeh; Mohammad Parsa-Kondelaji
Journal:  Clin Exp Med       Date:  2021-11-06       Impact factor: 5.057

Review 6.  Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS.

Authors:  Shahideh Amini; Aysa Rezabakhsh; Javad Hashemi; Fatemeh Saghafi; Hossein Azizi; Antoni Sureda; Solomon Habtemariam; Hamid Reza Khayat Kashani; Zahra Hesari; Adeleh Sahebnasagh
Journal:  J Intensive Care       Date:  2022-07-30

Review 7.  The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.

Authors:  Nicola Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576

Review 8.  SARS-CoV-2 Infected Patient: from a Hematologist's Perspective.

Authors:  Firas Kreidieh; Sally Temraz
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576

9.  ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy.

Authors:  Brandon Michael Henry; Stefanie W Benoit; Maria Helena Santos de Oliveira; Giuseppe Lippi; Emmanuel J Favaloro; Justin L Benoit
Journal:  Int J Lab Hematol       Date:  2020-12-03       Impact factor: 3.450

Review 10.  COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles.

Authors:  Richard C Becker; Travis Sexton; Susan Smyth
Journal:  J Thromb Thrombolysis       Date:  2021-08-04       Impact factor: 2.300
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.